TY - JOUR
T1 - Laser Capture Proteomics
T2 - spatial tissue molecular profiling from the bench to personalized medicine
AU - Liotta, Lance A.
AU - Pappalardo, Philip A.
AU - Carpino, Alan
AU - Haymond, Amanda
AU - Howard, Marissa
AU - Espina, Virginia
AU - Wulfkuhle, Julie
AU - Petricoin, Emanuel
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Introduction: Laser Capture Microdissection (LCM) uses a laser to isolate, or capture, specific cells of interest in a complex heterogeneous tissue section, under direct microscopic visualization. Recently, there has been a surge of publications using LCM for tissue spatial molecular profiling relevant to a wide range of research topics. Areas Covered: We summarize the many advances in tissue Laser Capture Proteomics (LCP) using mass spectrometry for discovery, and protein arrays for signal pathway network mapping. This review emphasizes: a) transition of LCM phosphoproteomics from the lab to the clinic for individualized cancer therapy, and b) the emerging frontier of LCM single cell molecular analysis combining proteomics with genomic, and transcriptomic analysis. The search strategy was based on the combination of MeSH terms with expert refinement. Expert Opinion: LCM is complemented by a rich set of instruments, methodology protocols, and analytical A.I. (artificial intelligence) software for basic and translational research. Resolution is advancing to the tissue single cell level. A vision for the future evolution of LCM is presented. Emerging LCM technology is combining digital and AI guided remote imaging with automation, and telepathology, to a achieve multi-omic profiling that was not previously possible.
AB - Introduction: Laser Capture Microdissection (LCM) uses a laser to isolate, or capture, specific cells of interest in a complex heterogeneous tissue section, under direct microscopic visualization. Recently, there has been a surge of publications using LCM for tissue spatial molecular profiling relevant to a wide range of research topics. Areas Covered: We summarize the many advances in tissue Laser Capture Proteomics (LCP) using mass spectrometry for discovery, and protein arrays for signal pathway network mapping. This review emphasizes: a) transition of LCM phosphoproteomics from the lab to the clinic for individualized cancer therapy, and b) the emerging frontier of LCM single cell molecular analysis combining proteomics with genomic, and transcriptomic analysis. The search strategy was based on the combination of MeSH terms with expert refinement. Expert Opinion: LCM is complemented by a rich set of instruments, methodology protocols, and analytical A.I. (artificial intelligence) software for basic and translational research. Resolution is advancing to the tissue single cell level. A vision for the future evolution of LCM is presented. Emerging LCM technology is combining digital and AI guided remote imaging with automation, and telepathology, to a achieve multi-omic profiling that was not previously possible.
KW - DCIS (Ductal Carcinoma in Situ)
KW - ERBB (Epidermal growth factor receptor family)
KW - Laser Capture Microdissection
KW - kinase signaling
KW - mass spectrometry
KW - neoadjuvant therapy
KW - phosphoprotein
KW - proteomics
KW - tissue spatial profiling
KW - tumor-host microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85121519831&partnerID=8YFLogxK
U2 - 10.1080/14789450.2021.1984886
DO - 10.1080/14789450.2021.1984886
M3 - Review article
C2 - 34607525
AN - SCOPUS:85121519831
SN - 1478-9450
VL - 18
SP - 845
EP - 861
JO - Expert Review of Proteomics
JF - Expert Review of Proteomics
IS - 10
ER -